British AIDS vaccine R&D
Executive Summary
Vaccine research firm Hiver (Human Immunodeficiency Virus Epidemic Research) has been created from the research base of three equity holders -- the Medical Research Council, the Imperial Cancer Research Fund and University College, London. Development of AIDS drugs and vaccines will be based on anti-idiotype technology. Hiver plans to license out any products developed.